Bone metastasis: orthopedic point of view
Keywords:
EF- Enfermedad metastásica MO- Metástasis óseas FP- Fractura patológica EOM- Enfermedad ósea metastásica IRM- Imagen de resonancia magnética TAC- Tomografía axial computarizadaAbstract
Background: cancer is a common cause of morbidity-mortality affecting many people internationally and nationally. One way of presentation is bone metastases.
Objective: to deepen the knowledge about the management of patients suffering from bone metastasis from a point of view of the Orthopedics and Traumatology specialties.
Methods: a search of information was carried out in a period of three months (January 1st, 2018 to March 31st, 2018) in the databases PubMed, Hinari, SciELO and Medline through the information locator EndNote by using the words bone metastasis, pathologic fracture, and metastatic bone disease, resulting in a total of 259 articles which 50 of them were selected for the review, 41 of them of the last five years, including ten books.
Development: bone metastasis types were described according to radiographic aspects as: litic, blastic and mix, so like the most common origin sites. The main stages were shown, specially the one related to the risk of pathologic fracture, so that criteria were stated to define treatment. Indication and treatment modalities were described, as well as prognostic factors.
Conclusions: metastatic bone disease is a great challenge for orthopedic surgeon, there are specific indications for surgery and one of the most important aspects to take in mind is the risk of pathologic fracture.
DeCS:NEOPLASM METASTASIS; NEOPLASMS, BONE TISSUE; BONE NEOPLASMS/surgery; FRACTURES, SPONTANEOUS; ORTHOPEDIC SURGEONS.
Downloads
References
1.Nousiainen M, Whyne CM, Yee AJM, Finkelstein J, Ford M. Surgical management of bone metastases. En: Kardamakis D. Bone metastases, cancer metastasis-biology and treatment. London: Springer; 2009.p.263-86.
2.Doddala SM, Suryadevara A, Chinta SK, Madisetty AL. Incidence and pattern of bone metastases at presentation in Indian carcinoma breast patients. Indian J Cancer. 2016 Jul-Sep; 53(3):360-2.
3.Klaassen Z, Howard LE, de Hoedt A, Amling CL, Aronson WJ, Cooperberg MR, et al. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer. Cancer. 2017 May;123(9):1528-35.
4.Capanna R, Piccioli A, Di Martino A, Daolio PA, Ippolito V, Maccauro G, et al. Management of long bone metastases: recommendations from the Italian Orthopaedic
Society bone metastasis study group. Expert Rev Anticancer Ther. 2014 Oct;14(10):1127-34.
5.Greenbaum SL, Thornhill BA, Geller DS. Characterization and surgical management of metastatic disease of the tibia. Am J Orthop (Belle Mead NJ).2017 Nov-Dec;46(6):E423-E428.
6.Guzik G. Oncological and functional results after surgical treatment of bone metastases at the proximal femur. BMC Surg. 2018 Jan; 18(1):5.
7.Charles T, Ameye L, Gebhart M. Surgical treatment for periacetabular metastatic lesions. Eur J Surg Oncol. 2017 Sep; 43(9):1727-32.
8.Creek AT, Ratner DA, Porter SE. Evaluation and treatment of extremity metastatic disease. In: Peabody TD, Attar S, editors. Orthopaedic Oncology. London: Springer; 2014.p.151-70.
9.Trujillo-González R, Nieto-Lucio L, Mendoza-Breton JA. Pathological fracture rate due to proximal femur metastasis at a referral hospital. Acta Ortop Mex.2016 Jul-Aug;30(4):176-80.
10.Arrigoni F, Bruno F, Zugaro L, Natella R, Cappabianca S, Russo U, et al. Developments in the management of bone metastases with interventional radiology. Acta Biomed.2018 Jan;89(1-S):166-74.
11.Dwivedi A, Srinivasan A, Kumar S, Trivedi S, Shukla VK, Shukla RC. The longest tumor diameter in one dimension as a predictor for skeletal metastasis in renal cell carcinoma. Indian J Cancer.2016 Jul-Sep;53(3):420-2.
12.Heck RK, Toy PC. Malignant tumors of bone. In: Azar FM, Beaty JH, Canale ST, editors. Campbell's Operative Orthopaedics. 13th ed. Philadelphia: Elsevier;2017.p.945-77.
13.Ameur WB, Belghali S, Akkari I, Zaghouani H, Bouajina E, Jazia EB. Bone metastasis as the first sign of gastric cancer. Pan Afr Med J.2017 Sep;28:95.
14.Singh G, Sharma D, Goyal S. Primary leiomyosarcoma of breast presenting with metastasis: an atypical presentation with dismal prognosis. Indian J Med Paediatr Oncol.2017 Oct-Dec;38(4):535-7.
15.Schirrmeister H, Arlandermir C. Diagnosis of skeletal metastases in malignant extraskeletal cancers. In: Heymann D, editor. Bone Cancer. Philadelphia: Elsevier;2010.p.283-93.
16.Rajarubendra N, Lawrentschuk N. Imaging of bone metastases. En: Heymann D, editor. Bone Cancer. Philadelphia: Elsevier;2010.p.269-81.
17.Greenspan A, Jundt G, Remagen W. Differential diagnosis of Orthopaedics Oncology. 2nd ed. Philadelphia:Lippincott Williams & Wilkins;2007.
18.Satoh T, Ledesma D, Yoshihara N. The economic burden of metastatic castration resistant prostate cancer and skeletal related events in Japanese University Hospitals. Asian Pac J Cancer Prev.2018 Jan;19(1):21-6.
19.Singh G, Rabbani SA. Bone metastasis. New Jersey: Human Press Inc; 2005.
20.Harding JJ, Abu-Zeinah G, Chou JF, Owen DH, Ly M, Lowery MA, et al. Frequency, morbidity, and mortality of bone metastases in advanced hepatocellular carcinoma. J Natl Compr Canc Netw.2018 Jan;16(1):50-8.
21.Kardamakis D, Vassiliou V, Chow E. Bone Metastasis: a translational and clinical approach. London: Springer; 2009.
22.Toy PC, Heck RK Jr. General principles of tumors. In: Azar FM, Beaty JH, Canale ST, editors. Campbell's Operative Orthopaedics. 13th ed. Philadelphia: Elsevier; 2017.p.830-87.
23.de Keizer B, Krijger GC, Ververs FT, van Es RJJ, de Bree R, Willems S. 68Ga-PSMA PET-CT Imaging of metastatic adenoid cystic carcinoma. Nucl Med Mol Imaging. 2017 Dec;51(4):360-1.
24.Hwang KE, Oh SJ, Park C, Jeon SJ, Lee JM, Cha BK, et al. Computed tomography morphologic features of pulmonary adenocarcinoma with brain/bone metastasis. Korean J Intern Med.2018 Mar;33(2):340-6.
25.Choi ES, Han I, Cho HS, Park IW, Park JW, Kim HS. Intramedullary nailing for pathological fractures of the proximal humerus. Clin Orthop Surg.2016 Dec;8(4):458-64.
26.Flais J, Coiffier G, Brillet E, Perdriger A, Guggenbuhl P. Atypical presentation of spine bone metastasis in prostate cancer mimicking Pott's disease. Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):239-40.
27.Yamashita S, Katsumi H, Sakane T, Yamamoto A. Bone-targeting dendrimer for the delivery of methotrexate and treatment of bone metastasis. J Drug Target.2018 Jan:1-32.
28.Mirel H. Metastatic disease in long bones. Clin Orthop. 1989 Dec;249:256-64.
29.Colman MW, Karim SM, Hirsch JA, Yoo AJ, Schwab JH, Hornicek FJ, et al. Percutaneous acetabuloplasty compared with open reconstruction for extensive periacetabular carcinoma metastases. J Arthroplasty.2015 Sep;30(9):1586-91.
30.Iyer KM. Bone tumors. En: Iyer KM, editors. General Principles of Orhopaedics and Trauma. London: Springer Verlag;2013.p.236-42.
31.Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer.2018 Jan;18(1):44.
32.Capanna R, Campanacci DA. The treatment of metastasis in the appendicular skeleton J Bone Joint Surg Br.2001 May;83(4):471-81.
33.Kang J, Formenti SC. Metastatic osseous pain control: radiation therapy. Semin Intervent Radiol.2017 Dec;34(4):322-7.
34.Kelekis A, Cornelis FH, Tutton S, Filippiadis D. Metastatic osseous pain control: bone ablation and cementoplasty. Semin Intervent Radiol.2017 Dec;34(4):328-36.
35.Sprave T, Welte SE, Bruckner T, Förster R, Bostel T, Schlampp I, et al. Intensity-modulated radiotherapy with integrated-boost in patients with bone metastasis of the spine: study protocol for a randomized controlled trial. Trials. 2018 Jan;19(1):59.
36.Arvanius C, Parra JL, Mateo LS, Maroto RG, Borrego AF, Stern LL. Benefits of early intramedullary nailing in femoral metastases. Int Orthop. 2014 Jan;38(1):129-32.
37.Capanna R, De Biase P, Campanacci DA. A new protocol of surgical treatment of long bone metastases. Orthop Traumatol Rehabil. 2003 Jun;5(3):271-5.
38.Higuchi T, Yamamoto N, Hayashi K, Takeuchi A, Kato S, Miwa S, et al. The efficacy of wide resection for musculoskeletal metastatic lesions of renal cell carcinoma. Anticancer Res. 2018 Jan;38(1):577-82.
39.Ormsby NM, Leong WY, Wong W, Hughes HE, Swaminathan V. The current status of prophylactic femoral intramedullary nailing for metastatic cancer. Ecancer medical science.2016 Dec; 10:698.
40.Ross PR, Kolovich GP, Mayerson JL. Harrington rod revision after failed total hip arthroplasty due to missed acetabular metastasis. Am J Orthop (Belle Mead NJ).2015 Mar;44(3):E75-7.
41.Shah-Nawaz MD, Savage J, Scharschmidt TJ, Patel A. Evaluation and treatment of spinal metastatic disease. In: Peabody TD, Attar S. Orthopaedic Oncology. London: Springer;2014.p.131-50.
42.Srikanth KP, Srinivas C, Gowrishankarswamy LG, Chandrasekar C. Endoprosthetic reconstruction for metastatic phaeochromocytoma in the distal femur: a case report. J Clin Orthop Trauma. 2016 Oct-Dec;7(Suppl 1):12-6.
43.Willeumier JJ, van der Linden YM, van de Sande MAJ, Dijkstra PD. Treatment of pathological fractures of the long bones. EFORT Open Rev. 2017 Mar;1(5):136-145.
44.Laredo JD, Mosseri J, Nizard R. Percutaneous nailing and cementoplasty for palliative management of supra-acetabular iliac wing metastases: a case report. JBJS Case Connect. 2017 Jul-Sep;7(3):e46.
45.Lozano-Calderon SA, Kaiser CL, Osler PM, Raskin KA. Cemented total hip arthroplasty with retrograde ischioacetabular steinmann pin reconstruction for periacetabular metastatic carcinoma. J Arthroplasty.2016 Jul;31(7):1555-60.
46.de Gori M, D’Arienzo A, Andreani L, Beltrami G, Campanacci DA, De Biase P, et al. Complications and survival of megaprostheses after resection of bone metastases. J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4 suppl 1):43-50.
47.Wang B, Chen W, Xie X, Tu J, Huang G, Zou C, et al. Development and validation of a prognostic index to predict pulmonary metastasis of giant cell tumor of bone. Oncotarget. 2017 Nov;8(64):108054-63.
48.Forsberg JA, Wedin R, Boland PJ, Healey JH. Can we estimate short- and intermediate-term survival in patients undergoing surgery for metastatic bone disease? Clin Orthop Relat Res. 2017 Apr;475(4):1252-61.
49.Izumi H, Igishi T, Yamasaki A, Takeda K, Yanai M, Tanaka N, et al. Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastases. Mol Clin Oncol. 2017 Dec;7(6):1000-4.
50.Piccioli A, Spinelli MS, Forsberg JA, Wedin R, Healey JH, Ippolito V, et al. How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations. BMC Cancer. 2015 May;15:424.
Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/
22 julio 2025